PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+15.75%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.89B
AUM Growth
+$1.89B
(+15%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
93
New
19
Increased
21
Reduced
14
Closed
17
Top Buys
| 1 |
Outset Medical
OM
|
$131M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$41.4M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$29.8M |
| 4 |
Avantor
AVTR
|
$28.6M |
| 5 |
Gilead Sciences
GILD
|
$25.6M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$156M |
| 2 |
McKesson
MCK
|
$50.5M |
| 3 |
Cardinal Health
CAH
|
$45.2M |
| 4 |
Labcorp
LH
|
$31.4M |
| 5 |
Baxter International
BAX
|
$25.4M |
Sector Composition
| 1 | Healthcare | 77.72% |
| 2 | Technology | 5.64% |
| 3 | Consumer Discretionary | 1.62% |
| 4 | Industrials | 0.9% |
| 5 | Utilities | 0.69% |
